Multiple Myeloma
Conditions
Interventions
Treatment Group:VM26+CTX+DXM regimen
Sponsors
Sun Yat-sen University Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Men and women, aged above 18 years; 2. Subjects have diagnosed multiple myeloma, and previously treated; 3. ECOG performance status (PS) score 0-2; 4. AST and ALT <=3 times the institutional ULN; Total bilirubin <=2.0 times the institutional ULN Serum creatinine<2.0 times the institutional ULN; 5. Women or men must take effective contraceptive measures, in women Serum or urine pregnancy tests must be negative in the screening and study periods; 6. Patients understand the disease and voluntarily received the study regimen and follow-up.
Exclusion criteria
Exclusion criteria: 1. Frail to receive chemotherapy; 2. Uncontrolled DM; 3. Subjects suffered from the AIDSactivity hepatitis B or C virus; 4. Dementia or altered mental status that would prohibit the understanding or rendering of informed consent;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete response rate;Overall response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression free survival;Overall survival; | — |
Countries
China
Contacts
Public ContactYue Lv
Outcome results
None listed